IPROTEASE Trademark

Trademark Overview

On Tuesday, July 2, 2013, a trademark application was filed for IPROTEASE with the United States Patent and Trademark Office. The USPTO has given the IPROTEASE trademark a serial number of 86001326. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 29, 2018. This trademark is owned by Alcresta, Inc.. The IPROTEASE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

medical nutritional formula; infant formula; enzyme food supplements and enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders, all of the foregoing comprised in whole or significant part of protease

Filters for medical purposes, namely, for processing and converting medical nutritional formula before it is administered to patients
iprotease

General Information

Serial Number86001326
Word MarkIPROTEASE
Filing DateTuesday, July 2, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 29, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2015

Trademark Statements

Goods and Servicesmedical nutritional formula; infant formula; enzyme food supplements and enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders, all of the foregoing comprised in whole or significant part of protease
Goods and ServicesFilters for medical purposes, namely, for processing and converting medical nutritional formula before it is administered to patients
Pseudo MarkI PRO TEASE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 17, 2014
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALCRESTA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEWTON, MA 02462
Party NameAlcresta, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02462
Party NameAlcresta, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02462

Trademark Events

Event DateEvent Description
Monday, October 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 29, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2018EXTENSION 5 GRANTED
Friday, February 23, 2018EXTENSION 5 FILED
Friday, February 23, 2018TEAS EXTENSION RECEIVED
Friday, September 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2017EXTENSION 4 GRANTED
Wednesday, August 30, 2017EXTENSION 4 FILED
Wednesday, August 30, 2017TEAS EXTENSION RECEIVED
Wednesday, March 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2017EXTENSION 3 GRANTED
Monday, March 6, 2017EXTENSION 3 FILED
Monday, March 6, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017ASSIGNED TO EXAMINER
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 15, 2016EXTENSION 2 GRANTED
Wednesday, September 21, 2016EXTENSION 2 FILED
Thursday, October 13, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 21, 2016TEAS EXTENSION RECEIVED
Wednesday, July 6, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, March 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2016EXTENSION 1 GRANTED
Wednesday, March 16, 2016EXTENSION 1 FILED
Wednesday, March 16, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2015EXAMINER'S AMENDMENT ENTERED
Monday, June 22, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 22, 2015EXAMINERS AMENDMENT E-MAILED
Monday, June 22, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 1, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 1, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 29, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 29, 2014FINAL REFUSAL E-MAILED
Monday, December 29, 2014FINAL REFUSAL WRITTEN
Thursday, December 4, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 4, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 4, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 5, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 5, 2014NON-FINAL ACTION E-MAILED
Thursday, June 5, 2014NON-FINAL ACTION WRITTEN
Tuesday, May 27, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, May 18, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, May 7, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 7, 2014ASSIGNED TO LIE
Tuesday, April 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 17, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 22, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2013NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2013NON-FINAL ACTION WRITTEN
Friday, October 11, 2013ASSIGNED TO EXAMINER
Tuesday, July 16, 2013NOTICE OF PSEUDO MARK E-MAILED
Saturday, July 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

iprotease nutritional medical formula purposes supplements muscular respiratory diseases disorders pulmonary